Extracorporeal shock wave therapy (ESWT) in the treatment of Peyronie's disease: our initial experience.

IF 1.3 Q3 UROLOGY & NEPHROLOGY

Archivio Italiano di Urologia e Andrologia Pub Date : 2026-03-31 Epub Date: 2026-03-02 DOI:10.4081/aiua.2026.14737

Giuseppe Saitta, Riccardo Trovato, Vincenzo Striano, Simone Di Salvatore, Giuseppe Di Paola, Andrea Simone Ceresoli, Franco Anacleto Mantovani, Attilio Luigi Meazza, Mauro Seveso

引用次数: 0

Abstract

Background: Peyronie's disease (PD) is a connective tissue disorder of the penis that causes pain, curvature, and erectile dysfunction. Methods: A prospective study was conducted on 112 patients treated with ESWT. Each received three sessions of 3,000 shockwaves at 0.11-0.17 mJ/mm2. Pain, curvature, and erectile function were assessed.

Results: Pain relief occurred in 90% of patients (mean VAS reduction: 3, p<0.00001); 57.1% had curvature improvement (mean 30°, p<0.001); 26.2% of ED patients improved ≥ 4 points in IIEF.

Conclusions: ESWT appears safe and effective in improving pain and curvature in PD patients.

查看原文本刊更多论文

体外冲击波疗法（ESWT）治疗佩罗尼氏病的初步经验。

背景：佩罗尼氏病（PD）是一种阴茎结缔组织疾病，引起疼痛、弯曲和勃起功能障碍。方法：对112例经ESWT治疗的患者进行前瞻性研究。每组接受三组3000次冲击波，冲击波强度为0.11-0.17 mJ/mm2。评估疼痛、弯曲度和勃起功能。结果：90%的患者出现疼痛缓解（平均VAS降低：3.0%）。结论：ESWT在改善PD患者疼痛和曲度方面安全有效。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊